Figure 1.

Clinical laboratory testing for safety monitoring

Study design including summaries of eligibility and monitoring with study visits illustrated by a timeline. Laboratory testing was performed at each study visit to monitor for liver or muscle toxicity, including serum ALT, AST, GGT, and CK.